GB0811856D0 - Magnetic microbubbles, methods of preparing them and their uses - Google Patents

Magnetic microbubbles, methods of preparing them and their uses

Info

Publication number
GB0811856D0
GB0811856D0 GBGB0811856.4A GB0811856A GB0811856D0 GB 0811856 D0 GB0811856 D0 GB 0811856D0 GB 0811856 A GB0811856 A GB 0811856A GB 0811856 D0 GB0811856 D0 GB 0811856D0
Authority
GB
United Kingdom
Prior art keywords
preparing
methods
magnetic microbubbles
microbubbles
magnetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0811856.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCL Business Ltd
Original Assignee
UCL Business Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCL Business Ltd filed Critical UCL Business Ltd
Priority to GBGB0811856.4A priority Critical patent/GB0811856D0/en
Publication of GB0811856D0 publication Critical patent/GB0811856D0/en
Priority to PCT/GB2009/001614 priority patent/WO2009156743A2/en
Priority to JP2011515596A priority patent/JP2011525899A/ja
Priority to EP20090769584 priority patent/EP2296620B1/en
Priority to US13/000,841 priority patent/US9427396B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Water Treatment By Electricity Or Magnetism (AREA)
  • Soft Magnetic Materials (AREA)
GBGB0811856.4A 2008-06-27 2008-06-27 Magnetic microbubbles, methods of preparing them and their uses Ceased GB0811856D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB0811856.4A GB0811856D0 (en) 2008-06-27 2008-06-27 Magnetic microbubbles, methods of preparing them and their uses
PCT/GB2009/001614 WO2009156743A2 (en) 2008-06-27 2009-06-26 Magnetic microbubbles, methods of preparing them and their uses
JP2011515596A JP2011525899A (ja) 2008-06-27 2009-06-26 磁性マイクロバブル、その作成方法及びその使用
EP20090769584 EP2296620B1 (en) 2008-06-27 2009-06-26 Magnetic microbubbles, methods of preparing them and their uses
US13/000,841 US9427396B2 (en) 2008-06-27 2009-06-26 Magnetic microbubbles, methods of preparing them and their uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0811856.4A GB0811856D0 (en) 2008-06-27 2008-06-27 Magnetic microbubbles, methods of preparing them and their uses

Publications (1)

Publication Number Publication Date
GB0811856D0 true GB0811856D0 (en) 2008-07-30

Family

ID=39683315

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0811856.4A Ceased GB0811856D0 (en) 2008-06-27 2008-06-27 Magnetic microbubbles, methods of preparing them and their uses

Country Status (5)

Country Link
US (1) US9427396B2 (enExample)
EP (1) EP2296620B1 (enExample)
JP (1) JP2011525899A (enExample)
GB (1) GB0811856D0 (enExample)
WO (1) WO2009156743A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2600229T3 (es) * 2009-11-12 2017-02-07 Helmholtz-Zentrum Geesthacht Zentrum für Material- und Küstenforschung GmbH Nanopartículas magnéticas biocompatibles para el tratamiento de glioblastomas
TWI491425B (zh) * 2010-11-26 2015-07-11 Univ Chang Gung Targeting drug administration system and its operation method
KR101292939B1 (ko) 2010-12-31 2013-08-02 삼성전자주식회사 엠알유도 고강도집속초음파 치료 및 진단용 인지질 나노입자 및 이의 제조방법
DE102011000264B4 (de) 2011-01-21 2019-01-17 Surflay Nanotec Gmbh Mikrogasbläschen mit PVA-Wand, Herstellung und Verwendung von solchen Mikrogasbläschen
CZ304301B6 (cs) * 2012-09-19 2014-02-19 Vysoké Učení Technické V Brně Způsob přípravy magneticky vodivých prášků s využitím kavitace a zařízení k provádění tohoto způsobu
WO2016115133A1 (en) * 2015-01-12 2016-07-21 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Polymer microbubbles as x-ray dark field contrast agents
JP6861803B2 (ja) * 2016-09-15 2021-04-21 ラブサイト インコーポレイテッド ソノポレーションを使用した生物学的細胞の高効率トランスフェクション
GB201716237D0 (en) * 2017-10-05 2017-11-22 Univ Oxford Innovation Ltd Magnetic-acoustic device
GB201716239D0 (en) * 2017-10-05 2017-11-22 Univ Oxford Innovation Ltd Compositions and methods for treating pseudoaneurysm
CN109946966B (zh) * 2019-03-15 2022-04-15 宁波大学 基于参数不确定量化的磁流体运动控制方法
US11883679B2 (en) * 2019-10-11 2024-01-30 North Carolina State University Systems and methods for ultrasound induced thrombolysis with magnetic microbubbles, optional nanodroplets, and a rotational magnetic field
GB201918428D0 (en) 2019-12-13 2020-01-29 Univ Oxford Innovation Ltd Functionalised microbubbles

Family Cites Families (152)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4331654A (en) 1980-06-13 1982-05-25 Eli Lilly And Company Magnetically-localizable, biodegradable lipid microspheres
US4652257A (en) 1985-03-21 1987-03-24 The United States Of America As Represented By The Secretary Of The Navy Magnetically-localizable, polymerized lipid vesicles and method of disrupting same
DE3529195A1 (de) 1985-08-14 1987-02-26 Max Planck Gesellschaft Kontrastmittel fuer ultraschalluntersuchungen und verfahren zu seiner herstellung
US4844882A (en) 1987-12-29 1989-07-04 Molecular Biosystems, Inc. Concentrated stabilized microbubble-type ultrasonic imaging agent
US5580575A (en) 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5305757A (en) 1989-12-22 1994-04-26 Unger Evan C Gas filled liposomes and their use as ultrasonic contrast agents
US6088613A (en) 1989-12-22 2000-07-11 Imarx Pharmaceutical Corp. Method of magnetic resonance focused surgical and therapeutic ultrasound
US5656211A (en) 1989-12-22 1997-08-12 Imarx Pharmaceutical Corp. Apparatus and method for making gas-filled vesicles of optimal size
US5230882A (en) 1989-12-22 1993-07-27 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5149319A (en) 1990-09-11 1992-09-22 Unger Evan C Methods for providing localized therapeutic heat to biological tissues and fluids
US5705187A (en) 1989-12-22 1998-01-06 Imarx Pharmaceutical Corp. Compositions of lipids and stabilizing materials
US5228446A (en) 1989-12-22 1993-07-20 Unger Evan C Gas filled liposomes and their use as ultrasonic contrast agents
US5209720A (en) 1989-12-22 1993-05-11 Unger Evan C Methods for providing localized therapeutic heat to biological tissues and fluids using gas filled liposomes
US5585112A (en) 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5123414A (en) 1989-12-22 1992-06-23 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5773024A (en) 1989-12-22 1998-06-30 Imarx Pharmaceutical Corp. Container with multi-phase composition for use in diagnostic and therapeutic applications
IN172208B (enExample) 1990-04-02 1993-05-01 Sint Sa
US20040208826A1 (en) 1990-04-02 2004-10-21 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
US5578292A (en) 1991-11-20 1996-11-26 Bracco International B.V. Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
US7083778B2 (en) 1991-05-03 2006-08-01 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
US20080063603A1 (en) * 1990-04-02 2008-03-13 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
US6613306B1 (en) 1990-04-02 2003-09-02 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
US5445813A (en) 1992-11-02 1995-08-29 Bracco International B.V. Stable microbubble suspensions as enhancement agents for ultrasound echography
US6989141B2 (en) 1990-05-18 2006-01-24 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
US5556610A (en) 1992-01-24 1996-09-17 Bracco Research S.A. Gas mixtures useful as ultrasound contrast media, contrast agents containing the media and method
US20030185759A1 (en) 1990-05-18 2003-10-02 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
AU636481B2 (en) 1990-05-18 1993-04-29 Bracco International B.V. Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
US20030194376A1 (en) 1990-05-18 2003-10-16 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
US5420176A (en) 1990-06-01 1995-05-30 Imarx Pharmaceutical Corp. Contrast media for ultrasonic imaging
US5215680A (en) 1990-07-10 1993-06-01 Cavitation-Control Technology, Inc. Method for the production of medical-grade lipid-coated microbubbles, paramagnetic labeling of such microbubbles and therapeutic uses of microbubbles
ES2074725T3 (es) 1990-10-05 1995-09-16 Bracco Int Bv Metodo para la preparacion de suspensiones estables de microesferas huecas llenas de gas adecuadas para ecografia ultrasonica.
US5370901A (en) 1991-02-15 1994-12-06 Bracco International B.V. Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients
GB9106673D0 (en) 1991-03-28 1991-05-15 Hafslund Nycomed As Improvements in or relating to contrast agents
GB9106686D0 (en) 1991-03-28 1991-05-15 Hafslund Nycomed As Improvements in or relating to contrast agents
MX9205298A (es) 1991-09-17 1993-05-01 Steven Carl Quay Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
GB9200388D0 (en) 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
IL104084A (en) 1992-01-24 1996-09-12 Bracco Int Bv Long-lasting aqueous suspensions of pressure-resistant gas-filled microvesicles their preparation and contrast agents consisting of them
US5698397A (en) 1995-06-07 1997-12-16 Sri International Up-converting reporters for biological and other assays using laser excitation techniques
US20050053552A1 (en) 1993-01-25 2005-03-10 Quay Steven C. Phase shift colloids as ultrasound contrast agents
US5411730A (en) 1993-07-20 1995-05-02 Research Corporation Technologies, Inc. Magnetic microparticles
DE69434119T3 (de) 1993-07-30 2011-05-05 Imcor Pharmaceutical Co., San Diego Stabilisierte mikrogasbläschen-zusammensetzungen für echographie
US7083572B2 (en) 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
DE4341478C2 (de) 1993-12-02 1998-10-08 Max Delbrueck Centrum Mittel zur Antitumortherapie
EP0682530B1 (en) 1993-12-15 2003-03-19 Bracco Research S.A. Gas mixtures useful as ultrasound contrast media
DE4412651A1 (de) 1994-04-13 1995-10-19 Mueller Schulte Detlef Dr Mittel zur selektiven AIDS Therapie sowie Verfahren zur Herstellung und Verwendung derselben
US5562893A (en) 1994-08-02 1996-10-08 Molecular Biosystems, Inc. Gas-filled microspheres with fluorine-containing shells
US6132764A (en) 1994-08-05 2000-10-17 Targesome, Inc. Targeted polymerized liposome diagnostic and treatment agents
US6333021B1 (en) 1994-11-22 2001-12-25 Bracco Research S.A. Microcapsules, method of making and their use
IL116328A (en) 1994-12-16 1999-09-22 Bracco Research Sa Frozen suspension of gas microbubbles in frozen aqueous carrier for use as contrast agent in ultrasonic imaging
DE19581906T1 (de) 1995-01-19 1998-01-08 Cate Folkert Jan Ten Lokale Abgabe bzw. Zuführung und Überwachung von Arzneimitteln
US6540981B2 (en) 1997-12-04 2003-04-01 Amersham Health As Light imaging contrast agents
US5997898A (en) 1995-06-06 1999-12-07 Imarx Pharmaceutical Corp. Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
US5558092A (en) 1995-06-06 1996-09-24 Imarx Pharmaceutical Corp. Methods and apparatus for performing diagnostic and therapeutic ultrasound simultaneously
US5897851A (en) 1995-06-07 1999-04-27 Sonus Pharmaceuticals, Inc. Nucleation and activation of a liquid-in-liquid emulsion for use in ultrasound imaging
US5804162A (en) 1995-06-07 1998-09-08 Alliance Pharmaceutical Corp. Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
HK1009321A1 (en) 1995-08-29 1999-05-28 Nitto Denko Corporation Microporation of human skin for drug delivery and monitoring applications
US5876683A (en) 1995-11-02 1999-03-02 Glumac; Nicholas Combustion flame synthesis of nanophase materials
PL328406A1 (en) 1996-02-19 1999-01-18 Nycomed Imaging As Improved contrast media
US5976501A (en) 1996-06-07 1999-11-02 Molecular Biosystems, Inc. Use of pressure resistant protein microspheres encapsulating gases as ultrasonic imaging agents for vascular perfusion
US20010051131A1 (en) 1996-06-19 2001-12-13 Evan C. Unger Methods for delivering bioactive agents
ES2200187T3 (es) 1996-07-03 2004-03-01 Altea Therapeutics Corporation Microporacion mecanica multiple de la piel o de la mucosa.
NZ334365A (en) 1996-08-02 1999-10-28 Nycomed Imaging As Use of a contrast agent comprising microbubbles of biocompatible gas stabilised by opsonisable amphiphilic material for ultrasound imaging of the liver
US6414139B1 (en) 1996-09-03 2002-07-02 Imarx Therapeutics, Inc. Silicon amphiphilic compounds and the use thereof
US5846517A (en) 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
WO1998017324A2 (en) 1996-10-21 1998-04-30 Marsden, John, Christopher Improvements in or relating to contrast agents
WO1998018497A2 (en) 1996-10-28 1998-05-07 Nycomed Imaging As Contrast agents
AU5161298A (en) 1996-11-25 1998-06-22 Imarx Pharmaceutical Corp. Perfluorinated-ether compositions as diagnostic contrast agents
US6344272B1 (en) 1997-03-12 2002-02-05 Wm. Marsh Rice University Metal nanoshells
GB9708240D0 (en) 1997-04-23 1997-06-11 Nycomed Imaging As Improvements in or relating to contrast agents
US20020159951A1 (en) 1997-05-06 2002-10-31 Unger Evan C. Novel targeted compositions for diagnostic and therapeutic use
US6416740B1 (en) * 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
AU7702798A (en) 1997-05-30 1998-12-30 Alliance Pharmaceutical Corporation Methods and apparatus for monitoring and quantifying the movement of fluid
US20010053384A1 (en) 1997-07-07 2001-12-20 James F. Greenleaf Site-directed transfection with ultrasound and cavitation nuclei
DE69819309T2 (de) 1997-08-12 2004-07-15 Bracco Research S.A. Verabreichbare formulierugen und ihre anwendung in mri
GB9717542D0 (en) 1997-08-19 1997-10-22 Nycomed Imaging As Process
GB9717588D0 (en) 1997-08-19 1997-10-22 Nycomed Imaging As Improvements in or relating to contrast agents
EP1024837A1 (en) 1997-10-21 2000-08-09 Nycomed Imaging As Ultrasound imaging with contrast agent targeted to microvasculature and a vasodilator drug
US6896659B2 (en) 1998-02-06 2005-05-24 Point Biomedical Corporation Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility
AU760697B2 (en) 1998-04-09 2003-05-22 Ge Healthcare As Use of particulate contrast agents in diagnostic imaging for studying physiological parameters
US20040170564A1 (en) 1998-04-22 2004-09-02 Roald Skurtveit Ultrasound contrast agent dispersions comprising gas and destabilising agent
DE69916822T2 (de) 1998-04-28 2005-04-21 Amersham Health As Oslo Verbesserung von trennungsverfahren
US6548048B1 (en) 1998-04-28 2003-04-15 Amersham Health As Lipopeptide stabilized microbubbles as diagnostic/therapeutic agents
GB9809776D0 (en) 1998-05-07 1998-07-08 Nycomed Imaging As Method
EP1077686B1 (en) 1998-05-15 2008-08-06 NASA/Johnson Space Center Externally triggered microcapsules
GB2340225B (en) 1998-08-03 2002-11-13 Boris Zachar Gorbunov A detector and method for detecting ultra-low concentrations of molecules
AUPP899899A0 (en) 1999-03-03 1999-03-25 Paragon Medical Limited Magnetic material
WO2000062818A1 (en) 1999-04-20 2000-10-26 Richard Leslie Edelson Differentiation of monocytes into functional dendritic cells
JP3200704B2 (ja) 1999-05-13 2001-08-20 経済産業省産業技術総合研究所長 機能的に配置された磁気粒子・リポソーム粒子複合体
DE19924668A1 (de) 1999-05-28 2000-11-30 Bayer Ag Substituierte alpha-Phenyl-beta-Ketosulfone
DE60031540T2 (de) 1999-06-28 2007-05-16 California Institute Of Technology, Pasadena Mikromechanische pump- und ventilsysteme
EP1202671A4 (en) 1999-08-13 2004-11-10 Point Biomedical Corp MICROPARTICLES USEFUL AS ULTRASONIC CONTRAST AGENTS FOR THE LYMPHATIC SYSTEM
AU6636000A (en) 1999-08-13 2001-03-13 Point Biomedical Corporation Hollow microspheres with controlled fragility for medical use
GB9920392D0 (en) 1999-08-27 1999-11-03 Nycomed Imaging As Improvemets in or relating to diagnostic imaging
US6180087B1 (en) 2000-01-18 2001-01-30 Mallinckrodt Inc. Tunable indocyanine dyes for biomedical applications
US6395257B1 (en) 2000-01-18 2002-05-28 Mallinckrodt Inc. Dendrimer precursor dyes for imaging
AU2001258127B2 (en) 2000-05-12 2005-11-10 Matregen Corp. Method of producing structures using centrifugal forces
US7109167B2 (en) 2000-06-02 2006-09-19 Bracco International B.V. Compounds for targeting endothelial cells, compositions containing the same and methods for their use
DE10040380B4 (de) 2000-08-11 2006-03-09 Schering Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Plaques
US20030147812A1 (en) 2001-12-11 2003-08-07 Friedrich Ueberle Device and methods for initiating chemical reactions and for the targeted delivery of drugs or other agents
CA2474509C (en) 2002-02-14 2012-01-31 Immunivest Corporation Methods and algorithms for cell enumeration in a low-cost cytometer
DE60332060D1 (de) 2002-02-15 2010-05-20 Nippon Soda Co Harz mit Ketenaldehyd-Copolymer
EP1587944A4 (en) 2002-03-01 2007-03-21 Dyax Corp KDR AND VEGF / KDR BINDING PEPTIDES AND THEIR USE FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
US7211240B2 (en) 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
EP1485328A1 (en) 2002-03-19 2004-12-15 California Institute Of Technology A method for integrating microparticles into mems
AUPS220302A0 (en) 2002-05-08 2002-06-06 Chang, Chak Man Thomas A plasma formed within bubbles in an aqueous medium and uses therefore
CA2418229A1 (en) * 2002-05-16 2003-11-16 Rohan Dharmakumar Microbubble construct for sensitivity enhanced mr manometry
CA2428896A1 (en) 2002-05-16 2003-11-16 Rohan Dharmakumar Microbubble construct for sensitivity enhanced mr manometry
US6919068B2 (en) 2002-05-17 2005-07-19 Point Biomedical Corporation Method of preparing gas-filled polymer matrix microparticles useful for echographic imaging
DE10224352A1 (de) 2002-06-01 2003-12-11 Mueller Schulte Detlef Thermosensitive Polymerträger mit veränderbarer physikalischer Struktur für die biochemische Analytik, Diagnostik und Therapie
AU2003253950A1 (en) 2002-07-17 2004-02-02 James P. Dailey Delivery of therapeutic agent affixed to magnetic particle
AU2003300043A1 (en) 2002-10-10 2004-05-04 Elizabeth Chambers Carriers attached to blood cells
WO2004069284A2 (en) 2003-02-04 2004-08-19 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
EP1592456A1 (en) 2003-02-13 2005-11-09 BRACCO IMAGING S.p.A. Contrast enhanced x-ray phase imaging
WO2004110279A1 (en) 2003-06-12 2004-12-23 Bracco Research Sa Blood flow estimates through replenishment curve fitting in ultrasound contrast imaging
US20060086834A1 (en) 2003-07-29 2006-04-27 Robert Pfeffer System and method for nanoparticle and nanoagglomerate fluidization
JP2007504944A (ja) 2003-09-10 2007-03-08 パランスキ ナフム ナノ粒子及びマイクロ粒子の製造方法
CN1215902C (zh) 2003-09-11 2005-08-24 复旦大学 一种具有核壳结构的磁性荧光双功能微球及其制备方法
CN1879065A (zh) 2003-09-12 2006-12-13 弗尔克斯破产财产公司 用于生物活性剂的定位传递的包含磁性成分和生物相容性聚合物的可磁靶向颗粒
US20050074506A1 (en) 2003-10-02 2005-04-07 Brainsgate Ltd. Targeted release of nitric oxide in the CNS circulation for modulating the BBB and treating disorders
US20050089471A1 (en) 2003-10-24 2005-04-28 Johnson Bruce F. Labeled ligands for lectin-like oxidized low-density lipoprotein receptor (LOX-1)
US20050089470A1 (en) 2003-10-24 2005-04-28 Johnson Bruce F. Labeled peptides for lectin-like oxidized low-density lipoprotein receptor (LOX-1)
US7329391B2 (en) 2003-12-08 2008-02-12 Applera Corporation Microfluidic device and material manipulating method using same
US20050175709A1 (en) * 2003-12-11 2005-08-11 Baty Ace M.Iii Therapeutic microparticles
CN1897978B (zh) 2003-12-22 2011-11-23 博莱科瑞士股份有限公司 具有用于反差成像的活性组分的充气微囊组件
US20080281205A1 (en) 2004-01-16 2008-11-13 Morteza Naghavi Methods and Apparatuses For Medical Imaging
WO2005086639A2 (en) 2004-02-10 2005-09-22 Barnes-Jewish Hospital Improved efficacy and safety of targeted particulate agents with decoy systems
WO2005079843A1 (ja) 2004-02-25 2005-09-01 Ttc Co., Ltd. 新規リポソーム
CN1667413A (zh) 2004-03-09 2005-09-14 中国科学院过程工程研究所 一种免疫磁性微球及其制备方法和用途
TW200600784A (en) 2004-06-02 2006-01-01 Sidney Kimmel Cancer Ct Imaging and therapeutic agents targeting proteins expressed on endothelial cell surface
DE102004036780A1 (de) 2004-07-29 2006-03-23 Dr. Kübler GmbH Verfahren zur In-vitro-Herstellung eines Stoffgemisches für ein tumorkrankes Individuum sowie Stoffgemisch für ein tumorkrankes Individuum
WO2007008220A2 (en) 2004-08-05 2007-01-18 Baylor Research Institute Gene or drug delivery system
JP2006045132A (ja) 2004-08-05 2006-02-16 Konica Minolta Medical & Graphic Inc リポソーム含有磁気共鳴造影剤
US7575738B2 (en) 2004-08-13 2009-08-18 General Electric Company Heat shock protein as a targeting agent for endothelium-specific in vivo transduction
CN101005858A (zh) 2004-08-18 2007-07-25 伯拉考开发股份有限公司 用于反差成像的充气微泡组合物
US20060049116A1 (en) 2004-09-03 2006-03-09 Subramanian Krupakar M Method and apparatus for bubble glow discharge plasma treatment of fluids
EP1655040A1 (en) 2004-10-08 2006-05-10 Bracco Imaging, S.P.A. Contrast agent formulations for the visualization of the lymphatic system
EP1810688A1 (en) 2004-11-10 2007-07-25 Konica Minolta Medical & Graphic, Inc. Pharmaceutical preparation containing coated magnetic particles and method for production thereof, and diagnosis therapy system
JP2008524203A (ja) 2004-12-17 2008-07-10 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 分子イメージングのためのターゲティング剤
EP1827506A2 (en) 2004-12-17 2007-09-05 Koninklijke Philips Electronics N.V. Targeting contrast agents or targeting therapeutic agents for molecular imaging and therapy
AU2005321543A1 (en) 2004-12-30 2006-07-06 Cinvention Ag Combination comprising an agent providing a signal, an implant material and a drug
AU2006209654A1 (en) 2005-01-28 2006-08-03 Konica Minolta Medical & Graphic, Inc. Pharmaceutical preparation containing magnetic vesicular particles, manufacturing method thereof and diagnostic therapeutic system
WO2006094951A1 (en) 2005-03-03 2006-09-14 Bracco Research Sa Medical imaging system based on a targeted contrast agent
WO2006102395A2 (en) 2005-03-22 2006-09-28 Medstar Health Inc Delivery systems and methods for diagnosing and treating cardiovascular diseases
WO2006122414A1 (en) 2005-05-17 2006-11-23 Matregen Corp. Depot for sustained and controlled delivery of methotrexate
RU2008107572A (ru) 2005-07-28 2009-09-10 Паскуале МОЗАИКО (CH) Способ получения средств для улучшения состояния систем и веществ, средство для улучшения состояния систем и применение этих средств для улучшения или оптимизации состояния систем и веществ
US20090312637A1 (en) 2005-08-03 2009-12-17 Koninklijke Philips Electronics, N.V. Ultrasound monitoring and feedback for magnetic hyperthermia
CN1315920C (zh) 2005-08-08 2007-05-16 北京师范大学 具有无机/有机核壳结构的磁性复合微球及其制备方法
WO2007028981A1 (en) 2005-09-08 2007-03-15 University Of Dundee Apparatus and method for sonoporation
GB0518273D0 (en) 2005-09-08 2005-10-19 Univ Dundee Apparatus and method for sonoporation
JP5452922B2 (ja) * 2005-09-13 2014-03-26 アフィメトリックス・インコーポレーテッド コード化されたマイクロ粒子
US8427160B2 (en) 2005-10-12 2013-04-23 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Susceptibility-matched multi-well sample holders for high-throughput screening by magnetic analysis
CN100560133C (zh) 2006-03-14 2009-11-18 中国人民解放军第二军医大学 磁性聚乳酸-羟基乙酸氧化酚砷纳米微球及其制药用途

Also Published As

Publication number Publication date
US9427396B2 (en) 2016-08-30
US20110172486A1 (en) 2011-07-14
WO2009156743A3 (en) 2010-07-15
JP2011525899A (ja) 2011-09-29
WO2009156743A2 (en) 2009-12-30
EP2296620B1 (en) 2015-05-13
EP2296620A2 (en) 2011-03-23

Similar Documents

Publication Publication Date Title
GB0811856D0 (en) Magnetic microbubbles, methods of preparing them and their uses
EG27167A (en) Microemulsifiers and methods of making and using same
IL248723A0 (en) Specific antibodies against the bcr complex and methods of using them
ZA201008450B (en) Sweetener,methods of preparing sweetener and applications thereof
EP2398494A4 (en) Proproteins and their methods of use
EP2334804A4 (en) COCULTURAL COMPOSITIONS AND METHODS
GB0917044D0 (en) Agents, uses and methods
SI2408337T1 (sl) Blazina, komplet in postopek izdelave
EP2367866A4 (en) POLYESTER, MANUFACTURING METHOD THEREFOR AND USE
GB0917054D0 (en) Agents, uses and methods
HUE042940T2 (hu) Anti-FXI antitestek és alkalmazási eljárások
ZA201008483B (en) Diazacarbazoles and methods of use
ZA201200226B (en) Opsin-binding ligands, compositions and methods of use
IL211623A0 (en) Anti-notch2 antibodies and methods of use
IL209548A0 (en) Diazacarbazoles and methods of use
EP2212251A4 (en) PROCESS FOR THE PRODUCTION OF CLUSTERBOR
ZA201203025B (en) Connector, and methods of use
GB2488494B (en) Solution, use and method of preparation thereof
GB0920642D0 (en) Anchor and methods
GB0912744D0 (en) Methods and uses
EP2296675A4 (en) ECHINODERM EXTRACTS, MANUFACTURING METHODS AND ITS USES
EP2205525A4 (en) PROCESS FOR THE PREPARATION OF CLUSTERBORON
EP2205524A4 (en) METHODS OF MANUFACTURING CLUSTER BORON
EP2350212A4 (en) POLYAMINO-ACETONITRILES, PROCESSES FOR PREPARING THEM AND USE THEREOF
IL208918A0 (en) Methods of preparing substituted heterocycles-149

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)